about
sameAs
The EMPA-REG outcome study: critical appraisal and potential clinical implicationsFertilizing a Patient Engagement Ecosystem to Innovate Healthcare: Toward the First Italian Consensus Conference on Patient EngagementPathogenesis of obesity and diabetes mellitus: insights provided by indirect calorimetry in humans.Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise.The role of non-alcoholic fatty liver disease in cardiovascular disease.Why does NAFLD predict type 2 diabetes?Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis.Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines.Free leptin index and thyroid function in male highly trained athletes.Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals.Energy metabolism in diabetic and nondiabetic heart transplant recipients.Fasting blood sample-based assessment of insulin sensitivity in kidney-pancreas-transplanted patients.Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy.Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation.Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.L-arginine-induced vasodilation of the renal vasculature is preserved in uremic type 1 diabetic patients after kidney and pancreas but not after kidney-alone transplantation.Postabsorptive and insulin-stimulated energy homeostasis and leucine turnover in offspring of type 2 diabetic patients.Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure.Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release.Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training.Insulin resistance to both glucose and aminoacid metabolism in a patient with Fatal Familial Insomnia.Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study.Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity.Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation.Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men.Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.NAFLD/NASH in patients with type 2 diabetes and related treatment options.Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.Lack of association of apoE ε4 allele with insulin resistance.Beta cell function during rapamycin monotherapy in long-term type 1 diabetes.A high carbohydrate meal yields a lower ischemic threshold than a high fat meal in patients with stable coronary disease.
P50
Q26748742-E742EEBA-2EB4-4446-8BD7-13090BDEF695Q33767695-2B73D654-5BED-4C2C-A887-243378F3AFD2Q34327169-B5CD5E9B-2B39-4DA3-9BC4-85779FFAC668Q34422016-860A534E-A7B3-4974-8BD7-B0FCC38111ECQ35688259-937D4582-DC4A-4456-BECA-71DAAA2814D4Q37400830-9C1DDA29-FD46-477C-BBEA-682D947AF6FCQ37584151-DF28F1FB-F57A-46AF-9941-022B5D4E6D5EQ37749348-D4EABFE0-72F1-48FE-9F8E-03387B540426Q37856880-AF1A25B4-842B-460C-BBC9-1F9665579043Q37869703-B1555363-0534-44DE-BF8A-0C46C8C0A90AQ38231876-2C5DA631-01E5-48C4-A20F-EEA88B32EE30Q42499875-4B484E69-C3B1-4375-BCAE-5F3ED933E795Q43272855-F9BF678C-C560-427E-B432-26B52A3C592CQ43418713-2C5A0AE8-1DAC-419C-871C-17D747EC249DQ43766430-AF95121C-CBDE-41E5-9E75-C7CD382086BAQ43903145-35716530-49DC-42CD-A26D-991F022333AAQ44231044-7CBAABE2-B701-4D39-965B-7EDB51FBC25AQ44495262-47AB55A8-7237-4161-A996-2F89D1D48179Q44584373-94437963-B0E1-4241-B11E-26365E5A04A4Q44599748-58E33767-6E4E-4F3C-9735-A41EE49AE16EQ44816810-83BF3BAD-A8D7-4936-A098-0D686EEC4EAEQ45124497-1984FA5A-D424-4E3E-B610-DB73B291E65CQ45182096-38FEAF0D-91BF-4145-A004-0B609787F0F8Q45187544-76AEAD62-C453-4704-891A-B07C1CBDAD31Q45929750-7AAEE6AF-2FB6-424E-941C-332DFC8831DDQ46247447-0C253F6E-9FBA-4172-B943-F1F695C40267Q46361653-C33709A7-FF84-4A02-855B-AAE920995A6DQ46368631-274E25D2-B3C0-4A22-AF3A-EB6C2444304DQ46707698-D8AE909F-F736-4D63-A886-7D101F7FDE70Q46843149-3118ED2C-5443-43EB-8C2D-B7E7BFD7974FQ46911925-D33CB3F5-D12F-4C95-AA75-B6164C16CC22Q46936115-C1327981-A2A8-4E3F-ADC8-8DE6C46C8FEDQ46957659-EA03FCAC-67FF-4C6C-99BA-46156099D9B1Q46970736-D63F6AD1-4648-48CD-87A8-D79516D3C0CAQ47592767-B550B00F-32F8-4169-8927-EBDC623B7AB8Q50424351-886F5FA6-567E-468B-A72A-3A7867E9835EQ51025352-0366B928-D40C-4566-821A-2DE82ECE8EBDQ51380227-B0DF8380-A9F7-4DA2-B0F4-8D687BC5D312Q51387648-D44B2315-2F80-4BFA-8483-47A7283AE3AEQ51416410-D846E8E0-54C9-4D6E-B683-B247D48D9194
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gianluca Perseghin
@ast
Gianluca Perseghin
@en
Gianluca Perseghin
@es
Gianluca Perseghin
@nl
type
label
Gianluca Perseghin
@ast
Gianluca Perseghin
@en
Gianluca Perseghin
@es
Gianluca Perseghin
@nl
prefLabel
Gianluca Perseghin
@ast
Gianluca Perseghin
@en
Gianluca Perseghin
@es
Gianluca Perseghin
@nl
P106
P1153
7003371451
P166
P21
P31
P496
0000-0002-3024-0457